Browsing Tag

Pfizer-BioNTech

Pfizer-BioNTech Begin Clinical Trials Of Covid-19 Vaccine Specific To Omicron Variant

Dr Sanjeev Dev Malik Jan 26, 2022

German biotechnology company BioNTech and US company Pfizer have started clinical trials of an Omicron-based Covid-19 vaccine candidate in healthy adults from 18 through 55 years of age, the companies have said. The trials would evaluate…
Read More...

UK Approves Pfizer-BioNTech Covid-19 Vaccine Children Aged 5 To 11

Dr Sanjeev Dev Malik Dec 22, 2021

Britain’s medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the watchdog found the shot was safe and effective. The country’s vaccines committee…
Read More...